Stroke, Vol 20, 1694-1699, Copyright © 1989 by American Heart Association
S Yoshida, JF Alksne, JM Seelig, MD Bailey, SS Moore and K Kitamura
This study was undertaken to examine the effect of uridine 5'- diphosphate,
administered intravenously or intraperitoneally, on cold injury-induced
brain edema in rabbits. Bolus injection or continuous intravenous infusion
of uridine 5'-diphosphate 26 hours after a lesion was established had
adverse effects, such as increased intracranial pressure and lowered
systolic arterial blood pressure and cerebral perfusion pressure for
approximately 10-29 minutes, but these parameters did not change
appreciably from 29 minutes to 3 hours after administration.
Intraperitoneally administered uridine 5'-diphosphate did not affect these
parameters appreciably during 3 hours. Thus, the intravenous administration
of uridine 5'-diphosphate is harmful under neurosurgical conditions. In
contrast, 10 mg/kg/day i.p. uridine 5'- diphosphate pretreatment and
posttreatment, beginning 24 hours before and continuing until 24 hours
after the insult, significantly reduced neurologic abnormalities, Evans
blue extravasation, water content in the injured gray matter, and
intracranial pressure without affecting water content in the white matter.
Intravenous dexamethasone pretreatment and posttreatment in this setting
significantly reduced only neurologic abnormalities. However, there were no
significant differences between intraperitoneal uridine 5'-diphosphate and
intravenous dexamethasone effects on cold-injured brain.
ARTICLES
Effect of uridine 5'-diphosphate on cryogenic brain edema in rabbits
Division of Neurosurgery, University of California, San Diego.
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1989 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |